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 3D bioprinting is a relatively new and very promising field that uses 
conventional 3D printing techniques and adapts them to print biological materials 
that are suited for use with cells. These bioprinters can be used to print cells 
encapsulated within biological "ink" (bio-ink) to create and customize complex 
three-dimensional tissues and organs. Our work has focused on developing a 
new bioprinter nozzle that addresses critical gaps with present-day bioprinters, 
namely, the lack of standardized, physiologically-relevant biomaterials, and their 
one nozzle per composition printing capacity. These shortcomings preclude 
printing a range of cellular and biomaterial compositions (including gradients of 
cells and matrix components) within a single tissue construct. 
Type I collagen oligomers, a new soluble collagen subdomain that falls 
between molecular and fibrillar size scales, are ideally suited for tissue 
fabrication.  This collagen formulation, which is produced according to an ASTM 
voluntary consensus standard, i) exhibits rapid suprafibrillar self-assembly 
yielding highly interconnected collagen-fibril matrices resembling those found in 
the body's tissues, ii) supports cell encapsulation, and iii) allows customized, 
multi-scale design across the broadest range of tissue architectures and physical 
properties. These properties, along with its superior physiologic relevance, 
 
x 
support the use of this biomaterial in the development of a bioprinting nozzle that 
is able to address the key gaps in the field of 3D bioprinting. 
After researching microfluidic mixing devices and current bioprinters, early 
iterations of a 3D bioprinting nozzle were designed and machined to mix three 
fundamental reagents required to form a broad array of collagen-fibril matrix 
compositions, namely oligomeric type I collagen (oligomer), oligomer diluent 
(diluent), and self-assembly reagent (S.A.R).  The nozzle was designed to mix 
specified proportions of these solutions using a combination of hydrodynamic 
focusing and twisted channel mixing mechanisms before depositing the self-
assembling collagen. Three syringe pumps were used to continuously drive 
varying flow rates of the three reagents to the nozzle, which allowed for the 
creation of a broad array of cell and matrix compositions, including fibril-density 
gradients.  
To validate nozzle performance, three experiments were conducted to 
define dispensing volume accuracy and precision, mixing quality, and functional 
performance of dispensed materials, including cells and matrix. 
In summary, the integration of standardized self-assembling collagens with 
this innovative fluidic mixer effectively minimizes the number of printing 
reservoirs, employs a single dispensing nozzle, and most importantly supports 
"on demand" fabrication of various tissue compositions.  This advanced 3D 
bioprinting technology, together with our mechanistic-based tissue engineering 
design principles, is expected to support customized design and fabrication of 






CHAPTER 1. INTRODUCTION 
Objectives 
What is the long-term goal? 
The goal of this research was to develop a prototype three-dimensional (3D) 
bioprinter fluidic mixing nozzle that accommodates i) standardized self-
assembling collagens; and ii) facilitates on demand fabrication of tissue 
constructs with a wide range of cell and matrix compositions, including gradients. 
Based on this engineering design problem, the specific aims of this project were: 
1. Design, build, and validate a prototype 3D bioprinting nozzle that 
accommodates self-assembling oligomeric type I collagen as the 
primary extracellular matrix (ECM) component, as well as cells. 
Nozzle performance will be characterized and validated in terms of 
i) dispensing accuracy over a range of volumes, flow rates, and 
syringe sizes; ii) mixing quality; and iii) maintenance of functional 
characteristics of delivered materials (i.e., structural-mechanical 
properties of deposited self-assembled collagen and cell viability). 
2. Demonstrate the ability of the prototype nozzle to fabricate a 
collagen fibril density gradient.  
 This work represents significant progress in the area of 3D bioprinting for 
two reasons. First, self-assembling oligomeric type I collagen, is ideally suited for 
tissue fabrication, compared to currently used biomaterials, since it facilitates 
encapsulation of cells within collagen-fibril microenvironments that more closely 




Second, the proposed design supports on demand dispensing of a broad 
range of cell and/or matrix composition and gradients from a single nozzle within 
the same tissue construct. This is an improvement over conventional bioprinter 
designs, which accommodate multiple reservoirs with a one-nozzle-one 
composition dispensing capacity. 
Background 
3D bioprinting has evolved from a field of science fiction, to a practical field with 
potential applications in wound care, in vitro pharmaceutical and chemical 
testing, and organ transplantation (Murphy 2014). Bioprinting was first defined in 
2004 at an international workshop as “the use of material transfer processes for 
patterning and assembling biologically relevant materials–molecules, cells, 
tissues, and biodegradable biomaterials– with a prescribed organization to 
accomplish one or more biological functions” (Mironov 2006).  More specifically, 
the goal of 3D bioprinting is re-create multicellular tissues and organs de novo 
(Mironov 2006). To date, great strides have been made to achieve this goal; such 
as the creation of tissue with pre-made channels for blood vessel attachment and 
human-scale, mechanically stable implants such as calvarial bone, cartilage and 
skeletal muscle (Zhang 2013, Kang 2016). These implants, while still in the realm 
of research in academia, provide visibility to what might be possible in future 
years for industry.  
These 3D bioprinted tissues, or “tissue constructs”, are becoming more 
common with increased knowledge and accomplishments in the 3D tissue culture 
field. The field of 3D tissue culture is also expanding due to its improved 
physiologic relevance over conventional 2D cell culture (Rimann 2012). This shift 
from 2D to 3D tissue culture has brought to light the importance of the ECM. 
Specifically, how matrix stiffness, architecture, and ligand presentation affects 
cells. In turn, this has increased the need for scientists to systematically control 
and vary the properties of the ECM to induce a desired cell behavior (Mason 




potential to address these fabrication needs for advanced design and 
construction of complex and scalable living tissues. 
 
Types of 3D Bioprinters 
At present, there are three categories of 3D bioprinters, including inkjet, laser 
induced forward transfer (LIFT), and microextrusion (Murphy 2014). Each of 
these has its own advantages and disadvantages that make it well suited for 







Figure 1. The three different types of bioprinters currently used for 3D bioprinting. (a) 




Inkjet bioprinters are very common; partly because in the early days of 3D 
bioprinting, you could very easily modify commercially available inkjet printers to 
print cells (Murphy 2014). The inkjet nozzle is used to place precise volumes of 
cells suspended in a biomaterial that are stored in a modified ink cartridge, just 
like the commercial inkjet printers. This, coupled with control over the x, y and z-
axis, makes it possible for researchers to print droplets on the scale of pico-liters, 
at speeds of up to 10,000 drops/second, to create layers of cells with very high 
resolution (Murphy 2014). Researchers now use mostly thermal (Cui 2012) or 





The advantages of this style of bioprinting is the high cell viability (>80%), 
and high resolution (Horváth 2015). The disadvantages include the high 
susceptibility of nozzle clogging during the print, and the low volume dispensed 
per second when compared to other bioprinters (Ozbolat 2013). Because these 
printers lack the ability to print milliliters of biomaterial per second, like 
microextrusion printers, they are not typically used to create large tissue 
constructs. However; these bioprinters have been used in applications such as 
the creation of skin and cartilage (Skardal 2012, Cui 2012), where the total 
volume of the tissue construct is low, and can be created by stacking two-
dimensional sheets of patterned cells.  
 
Laser Induced Forward Transfer Bioprinting (LIFT)  
LIFT 3D bioprinters are similar to inkjet bioprinters, but were made to overcome 
nozzle clogging limitations (Duocastella 2007). The mechanism underlying LIFT 
is arguably the most complicated of the three types being addressed, but a brief 
summary should aid in understanding the advantages of this type of bioprinter. 
LIFT requires three components: a laser, a ribbon, and a substrate 
(Guillotin 2010). The ribbon is composed of a thin, transparent material, such as 
quartz or glass, which has a thin film of metal such as gold or titanium coated on 
one side. A thin layer of the biomaterial with encapsulated cells is applied to the 
metal film, and this whole component is flipped upside-down so the cells are 
facing down, and the side of the transparent material without a metal coating is 
facing upwards. A pulsing laser is then directed onto the top side of the thin metal 
layer, through the transparent material. The laser heats the metal to a plasma 
state, and this causes a shockwave that expels the biomaterial directly under the 
laser. The expelled biomaterial lands on the receptor substrate, which varies 
depending on the study, but can be as simple as a glass slide for imaging 




Surprisingly, the heating of metal to a plasma state has very little effect on 
the cells or proteins (Guillotin 2010). LIFT bioprinters have cell viabilities on par 
or exceeding that of inkjet bioprinters, often above 90% (Murphy 2014), and do 
not suffer from clogging like inkjet bioprinters. LIFT bioprinters also operate at 
speeds which are very comparable to inkjet bioprinters (Mézel 2010). The 
droplets can be small enough to contain only one encapsulated cell (Duocastella 
2007) or up to 5-7 encapsulated cells (Guillemot 2010). The issue with these 
small droplet sizes is that when the droplets are patterned in an array of 
individual droplets, they will evaporate. This challenge is overcome by the 
addition of glycerol to many LIFT biomaterials. However, if the glycerol content 
exceeds 10% v/v, it will compromise cell viability (Guillemot 2010). Another 
limitation of this type of bioprinter is the inability to print large-scale tissue 
constructs, much like inkjet bioprinters. LIFT has been used to create smaller 
tissue constructs (on the order of mm) such as cardiac patches that were later 
implanted into mice suffering from myocardial infarction (Gaebel 2011), and used 
extensively to create two-dimensional cell patterns (Guillemot 2010, Guillotin 
2010, Duocastella 2007). 
 
Microextrusion Bioprinting  
The main type of 3D bioprinter that will be focused on in this work is 
microextrusion. The basis of microextrusion bioprinting is the same as extrusion-
deposition 3D printers that have become popular with hobbyists and 
professionals (Ozbolat 2016). The main difference is instead of depositing 
plastic, the printer deposits a biocompatible material capable of cell 
encapsulation.  
Most microextrusion bioprinters work by holding the ECM biomaterial in a 
reservoir in its liquid state. As such, biomaterials that undergo self-assembly, or a 
fluid to gel transition are utilized. Pressure is applied to the reservoir, by either 




out of the reservoir and through an extrusion nozzle (usually outfitted with a 
syringe needle), as shown in Figure 1b. The nozzle deposits the biomaterial on 
the stage, where it is then converted into its gel-like state, most commonly done 
by means of photopolymerization (Kolesky 2014) or addition of an ionic 
crosslinking solution (Ozbolat 2014). An x-y-z robotic gantry system positions the 
extrusion nozzle over a platform where the tissue construct is created, point-by-
point or layer-by-layer.  
Modifications to this design have resulted in 3D bioprinters with multiple 
reservoirs and extrusion nozzles (Duan 2013, Smith 2004, Skardal 2010, 
Schuurman 2010, Wüst 2010, Pati 2014), and specialized nozzles to create 
complex geometries (Zhang 2013, 2015), shown in Figures 2a and 2b, 
respectively. Advantages of this bioprinter technology include i) the ability to print 
in high cell densities, ii) the ability to print large tissue constructs with moderate 
complexity, and iii) ease of use. The disadvantages are decreased cell viability, 
thought to be caused by the shear forces exerted on the cells in a viscous fluid, 
compared to the other types of 3D bioprinting, and decreased resolution (Ozbolat 
2013). Arguably the most impressive tissue constructs have come from 
microextrusion bioprinters, such as the creation of human-scale, implantable 
tissues, such as calvarial bone, that show new blood vessel formation and host 





Figure 2. Modifications made to conventional microextrusion bioprinters that a) add the 
ability to print more than one bio-ink, and type of bio-ink, and b) allow for the printing of 
hollow hydrogel tubes (Schuurman 2011, adapted from Zhang 2013). 
 
Table 1. Summary of the main features of each type of bioprinter (Murphy 2014). 
Type of 
Bioprinter 
Resolution Cell Viability Printed Cell 
Densities 
Applications 
Inkjet μm >85%% <106 Thin layer tissue 
replacement and patches 
LIFT μm >95% <108 Thin layer tissue 
replacement and patches 
Microextrusion mm 40-80% High Human-scale tissue 
replacement 
 
Bottom-up Versus Top-down Tissue Fabrication 
These three types of bioprinters use two distinct methods to create tissue 




bottom-up approach to create tissue constructs. This approach aims to mimic the 
heterogeneity of the cells, matrix, and growth factors of in vivo tissues with high 
spatial resolution (up to 1μm) printing of these components (Guillotin 2010). 
Using this method, researchers can attempt to mimic the organization and spatial 
distributions of various cell population, matrix components, and growth factor 
within a tissue, with the hope that the engineered tissue construct will function 
similarly to the target tissue. Using this method, researchers have been able to 
deposit droplets of biomaterial encapsulated cells (1-10 cells/droplet) with micron 
precision to create complex patterns, as demonstrated in Figure 3.   
Figure 3. The precise deposition of cells in a specific pattern using the high resolution 
capacity of a LIFT bioprinter a) before the addition of 1% w/v alginate, and b) after the 
addition of alginate (Guillotin 2010). 
 
In contrast, microextrusion bioprinting works by using the top-down 
approach. Microextrusion bioprinters do not have as high of resolution as LIFT or 
inkjet bioprinters, so they are unable to deposit cells and growth factors with the 




general shape and bulk mechanical properties of the tissue (such as stiffness), 
and deposit fewer cell types that have the potential to later differentiate and 
proliferate into a more heterogeneous cell population that more closely 
resembles native tissue. (Ozbolat 2014). This method relies on having a 
microenvironment that the cells can remodel, and a biomaterial that has the 
mechanical properties that allow it to hold its shape. With this method, 
researchers have been able to create tissue constructs that closely mimic the 
shape and structure of complex tissues, as shown in Figure 4.  
Figure 4. The deposition of individual high density cell spheroids to form a hollow, 





Gap in current 3D bioprinters 
One gap in current microextrusion bioprinters is the inability to print 
heterogeneous tissue constructs, that is tissues containing various cells and/or 
matrix densities. The more complex microextrusion bioprinters have multiple 
reservoirs for different cell types and different materials, but the density (or 
concentration) of the biomaterial in all of the reservoirs is kept constant. As a 
result, these bioprinters are unable to achieve continuous gradients in cellular 
and/or matrix components as is found within natural tissues (e.g., skin, cartilage) 
in vivo. Therefore, the need exists for a bioprinter that allows the user to control 
and change the density of the matrix and/or cells within the same tissue 
construct. This new level of control will allow for more complex tissue constructs 
to be created, and more research to be done on the effects of heterogeneous 
ECM concentration and stiffness within tissue. 
 
Biomaterial properties  
While each bioprinter type uses specific biomaterials and biomaterial formats as 
their bio-ink, all biomaterials must fulfill three design criteria; i) biocompatibility, ii) 
printability, and iii) physiologic relevance. 
One main design criterion for 3D bioprinter biomaterials is biocompatibility. 
The material that is printed will eventually serve as the ECM for the encapsulated 
cells. Therefore, the cells must be able to survive and execute fundamental 
behaviors, including proliferation, migration, differentiation, and morphogenesis. 
When thinking about biocompatibility, it is also important to know if and how the 
biomaterial will degrade. Biomaterial degradation mechanisms (cell-induced, 
proteolytic degradation or hydrolysis), byproducts produced, and how to control 
the degradation rate are all important considerations (Murphy 2014). Degradation 





properties of the scaffold and some degradation products have been shown to 
decrease cell viability (Hourd 2015, Lee 2016).   
The second biomaterial design criterion is printability. Viscosity and 
curing-time are the primary factors that determine printability. The material must 
be viscous enough to hold its shape until the material converts into a more gel-
like state, or polymerizes. This polymerization can take anywhere from a few 
seconds to a few minutes and is known as gelation-time (Murphy 2013). Many 
materials do not initially have favorable printing properties, but in order to be 
used for 3D bioprinting applications, they are modified with exogenous 
crosslinking agents for photo-polymerization, chemical polymerization, or ion-
polymerization (Suri 2011, Rutz 2015, Rodrigues 2012).  
The final biomaterial property that must be considered is physiologic 
relevance. Physiologic relevance describes the similarities of the biomaterial to 
the native ECM within the tissue of interest. It is not enough for the cells to 
survive in the biomaterial (biocompatibility). For the true potential of the cells to 
be realized, they must be able to proliferate, migrate, differentiate, and remodel 
the environment around them, as they would in vivo. Properties of physiologic 
relevance include the presence of ligands that would normally be found in vivo, a 
chemical structure of the biomaterial that closely resembles native tissue, and 
matching stiffness and concentration of the native ECM. All of the current 
biomaterials used in 3D bioprinting are evaluated against these three criteria.   
 
Current biomaterials used in 3D bioprinting  
Biomaterials used in 3D bioprinting can be divided into two categories: synthetic 
or naturally-derived polymers (Murphy 2014).  
Synthetic polymers are any polymeric biomaterial that is man-made. The 
advantage of synthetic polymers is the ability to tune the chemical properties for 




porosity can all be controlled for the experiment (Kolesky 2014). The 
disadvantages of synthetic polymers is the lack of physiologically-relevant 
architecture and biological signaling capacity. For this reason, synthetic polymers 
are often used in conjunction with naturally-derived polymers or functional motifs 
(e.g., cellular binding domains) derived from these polymers. The naturally-
derived polymer contains the cells, and is printed around a scaffold of synthetic 
polymer that provides mechanical integrity. Examples of popular synthetic 
biomaterials include polyethylene glycol (PEG), polycaprolactone (PCL), and 
pluronic F127. 
Naturally-derived biomaterials are derived from a natural source. 
Naturally-derived biomaterials encompass both nature-derived and tissue-
derived biomaterials. Tissue-derived biomaterials are specifically derived from 
animal tissue. The advantage of tissue-derived polymers is their biocompatibility 
and physiologic relevance. In 3D bioprinting, these biomaterials are often used to 
encapsulate cells. The disadvantages of these polymers include high lot-to-lot 
variation, poor mechanical integrity and lack of tunability. Properties like stiffness, 
porosity, degradation rate, and curing-time have historically not been controlled 
or characterized, leading to poor reproducibility within and between laboratories. 
To combat this, synthetic polymers are often used in the same tissue construct, 
as previously stated. Nature-derived biomaterials are derived from materials 
found in nature, but not animal tissue. These biomaterials often have similar 
biocompatibility characteristics to tissue-derived biomaterials, but lack 
physiologic relevance. Of the numerous nature-derived polymers used in 3D 
bioprinting, there are three that make up the majority: sodium alginate, gelatin 
methacrylate (GelMA), and type I collagen (Ozbolat 2016). 
 
Sodium Alginate  
Sodium alginate is arguably the most common biomaterial due to its wide 




alginate is a nature-derived block copolymer that is typically harvested from 
brown seaweed, and is composed of different ratios of two monomers: guluronic 
acid and mannuronic acid, or G units and M units, respectively (Rowley 1999). 
Two molecules of alginate bind together between G units when a di-valent or tri-
valent metal ion bonds to one strand of alginate, and a separate strand also 
binds to the same ion, as shown in Figure 5. The resulting structure entraps the 
ions similar to eggs in a carton, which results in the name “egg box” model 
(Sachan 2009). The addition of these ions causes alginate to form a gel, and the 
ability of alginate to undergo gelation with only the addition of ions, like Ca2+, as 
well as rapid gelation time, makes it an attractive biomaterial to use for 
bioprinting (Murphy 2013). However, because alginate is not found naturally in 
the body, this biomaterial lacks the inherent biological signaling capacity found in 
biomaterials derived from animal tissue. This means mammalian cells are unable 
to degrade and modify the alginate because they lack the enzymes to cleave the 
polymer chain (Lee 2012). Mammalian cells are also unable to interact with 
alginate gels due to the discouragement of protein adsorption by the hydrophilic 
nature of alginate (Rowley 1999).  
Figure 5. Molecules of alginate being bound together in an “egg box” formation by the 
addition of sodium ions (Lee 2012). 
 
GelMA  
Gelatin methacrylate is a very popular biomaterial that is advantageous for its 




than non-tissue derived biomaterials, such as alginate (Skardal 2014). Gelatin is 
derived from the partial hydrolysis of collagen, the most abundant protein in the 
ECM of animals (Gómez-Guillén 2011, Stenzel 1974). The partial hydrolysis of 
collagen breaks down the triple helix molecular structure, but keeps many of the 
arginine-glycine-aspartic acid sequences (RGDs) that promote cell attachment in 
vivo. The hydrolysis also does not affect the regions of the protein that are 
susceptible to degradation by matrix metalloproteinases (MMPs); the enzyme 
used by mammalian cells to degrade and remodel the local ECM (Yue 2015). 
When gelatin is cooled, there is an incomplete regain of the triple helix structure, 
and the gelatin solidifies (Van Den Bulcke 2000). This leads to a biomaterial with 
much greater physiologic relevance than synthetic or non-animal derived 
biomaterials.  
One of the major disadvantages with this material is its gelation. 
Polymerization of gelatin without any additives is thermally reversible, and gels 
will revert back to a liquid state at physiologic temperatures. One of the more 
popular ways to stabilize the gel is to add methacrylic anhydride (MA), which 
binds to the amine and hydroxyl groups of the gelatin, and causes the permanent 
gelation of the combined materials (GelMA) upon exposure to UV light (Yue 
2015), and in presence of a photoinitiator, as illustrated in Figure 6. The addition 
of MA only affects 5% of the amino acid residues in molar ratio (a degree of 
substitution, DS, of 5%), so it is thought that the vast majority of RGDs are still 
available to interact with the cell (Van Den Bulcke 2000). Because of its photo-
polymerization capacity, GelMA has been used extensively to create very 
complex and very small shapes that are much more easily made via the precise 




Figure 6. The polymerization of a) pure gelatin into helical structures, when temperature 
(t) decreases, and subsequent dissociation when the temperature is increased; and b) 
the polymerization of GelMA with a low degree of substitution (DS) in presence of UV 
light, photoinitiator and decreased temperature, resulting in both helical bonds and 
chemical crosslinks, and subsequent dissolution of the helical bonds upon heating 
(adapted from Van Den Bulcke 2000). 
 
Collagen Type I 
Type I collagen is an abundantly used biomaterial in 3D bioprinting because of its 
physiologic relevance and its ability to self-assemble in vitro and in vivo (Murphy 
2013). The fundamental building block of collagen is tropocollagen, or 
telocollagen, and consists of a triple helical structure, capped by short telopeptide 
regions. These telopeptide regions participate in the self-assembly of 
tropocollagen into microfibrils, which further assemble into fibrils in a fibrillar 
matrix structure (Bailey 2011).  
Monomeric collagen formulations, telocollagen and atelocollagen, have 
traditionally been used as biomaterials for 3D bioprinting. However, these 
formulations have been shown to suffer from variable purity and poor self-
assembly capacity (Abraham 2008).  Upon neutralization to physiologic pH and 




entangled individual fibrils, as shown in Figure 7a, and because of the lack of 
suprafibrilar assembly, the resulting matrix often suffers from poor mechanical 
integrity and shape definition (Blum 2016). For monomeric collagen, gelation is 
induced by increasing the temperature of neutralized solutions to physiologic 
temperatures. This makes them an attractive biomaterial for the sake of 
simplicity, but this polymerization process takes longer (typically 30 minutes or 
greater) than many other biomaterials used in bioprinting. To compensate, 
another biomaterial is often used to help collagen retain its shape (Chang 2011). 
The benefit of monomeric collagen is that it self-assembles into a fibril format, 
providing superior physiologic relevance when compared to almost all other 
biomaterials. However; even though this biomaterial is more physiologically 
relevant than many other popular biomaterials used in 3D bioprinting, there is still 
a need for a better biomaterial. 
Oligomeric collagen formulations are comprised of molecular aggregates 
of telocollagen molecules (e.g., trimer) that uniquely retain their natural 
intermolecular crosslinks (Bailey 2011). Compared to conventional collagen 
monomers, oligomers exhibit more robust, rapid, and superior fibril-matrix 
assembly, yielding highly interconnected collagen-fibril materials (Kreger et al. 
2010, Bailey et al. 2011).  Because oligomers exhibit both fibrillar and 
suprafibrillar assembly, they support user customization and tunability across the 
broadest range of fibril architectures and mechanical properties. Tuning fibril 
density is achievable by controlling collagen concentration, as they are directly 
related (Kreger et al. 2010). As shown in Figure 7b, the structure resulting from 
the self-assembly of these molecules leads to matrices with suprafibrillar and 
fibrillary organization. This, in turn, leads to decreased gelation time, increased 
physiologic relevance, increased mechanical properties, and increased tunability 
when compared to monomeric collagen. Oligomeric collagen is the only 
formulation that is standardized (ASTM Standard F3089-14) and quality 
controlled based upon its molecular composition and polymerization capacity, 





Figure 7. Summary of the assembly of monomeric and oligomeric type I collagen both in 
vivo  and in vitro into fibril matrices (Blum 2016).  
  
Gap in current biomaterials 
There is one property of biomaterials used in 3D bioprinting that is consistently 
overlooked: physiological relevance. Although type I collagen is the most 
physiologically relevant biomaterial, as it is the most abundant protein in the ECM 
of humans (Stenzel 1974), many 3D bioprinters modify its chemistry for better 
printability or mechanical integrity. This is because most collagen used in 3D 
bioprinting is poorly characterized, has uncontrollable gelling, and has poor 
mechanical integrity (Jang 2016). What is needed is a type I collagen biomaterial 
that is well characterized and mechanically stable, and a 3D bioprinter that is 
able to take advantage of the superior tunability of this biomaterial.  




physiologically-relevant biomaterial, without the addition of exogenous chemicals, 
would allow researchers to study tissue constructs that more closely recapitulate 
the native in vivo tissue. 
 
Recapitulation of Tissue and Organ Heterogeneity 
All tissues are composed of cells and an ECM, organized to address specific 
structural and functional demands of the tissue. Not only does tissue function 
vary widely within the body, it also varies widely within tissues and organs 
themselves. Because of this heterogeneity within tissues, complex architectures 
such as gradients of cellular and ECM components are often found in vivo.  
ECM stiffness and concentration differ greatly in the body (Justin 2011); 
not only between different types of tissue, but also within tissues themselves 
(Wells 2008). For instance, the stiffness of brain tissue is around several hundred 
pascals (Pa), but the stiffness of muscle is more than 12 Kilopascals (kPa), and 
the stiffness in the liver alone can range from 300 to 600 Pa in healthy tissue, 
and up to 20 kPa in diseased tissue (Wells 2008). Continuous ECM stiffness 
gradients are also found in the body, such as in the ligament-to-bone interface, 
as shown in Figure 8, and in the deeper layers of skin (Justin 2011). This 
knowledge has led to studies on the effect of ECM concentration, and stiffness 





Figure 8. Schematic of the tendon-to-bone interface (adapted from Seidi 2011). 
 
The fact that ECM stiffness gradients affect cell function has been well 
established (Shamloo 2010). Cells sense the change in ECM stiffness with 
surface receptors known as integrins (Friedl 1998). Integrins on the surface of 
cells bind to ligands in the ECM in order to move the cell during migration. The 
activation of these receptors causes the regulation of many different pathways 
within the cell, which cause various cell behaviors such as cell migration 
(Georges 2005). However, many studies regarding the effect of ECM stiffness on 
cell behavior have been done in 2D. This has been done to extricate confounding 
variables that accompany increasing the stiffness of a 3D matrix, such as 
decreased porosity and an increase in the number of ligand-adhesion points for 
cells (Georges 2005). Considering the primary goal of these studies has been to 
characterize the effect of ECM stiffness alone, removing confounding variables is 
to be expected. These studies have also been performed exclusively in 2D due 
to the lack of well characterized and tunable biomaterials that can be used for 3D 
cell studies (Mason 2013, Gu 2016).  
From 2D studies, ECM substrate stiffness has been shown to play a major 
role in development (Justin 2011), cancer progression (Lu 2012), disease 




differentiation (Justin 2011). While these studies show a clear effect of the 
substrate stiffness on different cell functions, it is well known that the results 
might not translate when performed in a 3D environment. Doing experiments 
such as these in 3D matrices that are physiologically relevant is important to 
increasing our understanding of how ECM concentration and stiffness affects 
cells in vivo.  
Fortunately, there have been in vitro studies in 3D cell cultures that prove 
that ECM stiffness and concentration have similar effects on cells. For instance, 
in the area of vasculogenesis, varying ECM stiffness causes morphological 
changes in the resulting vascular network (Whittington 2013). Unlike 2D studies, 
3D experiments are often not able to remove the confounding variables such as 
variable ligand density, but they more closely recapitulate the in vivo cellular 
microenvironment (Hadjipanayi 2009). A further benefit of performing ECM 
concentration and stiffness experiments in 3D matrices is allowing users to 
observe cellular phenomenon that only happen naturally in 3D, such as the 
formation of a vacuole in vasculogenesis or angiogenesis. 
It is clear that in order to have tissue constructs that recapitulate the ECM 
found in vivo, there must be a focus on matching the heterogeneity of native 
ECM concentration and stiffness. That is why I have proposed a novel 3D 
bioprinting nozzle to address this issue. 
 
Proposed 3D Bioprinter 
The bioprinting nozzle was designed to accomplish the following goals:  
1. Combine and mix the three reagents of oligomer, diluent, and 
S.A.R continuously, over the course of printing the tissue construct. 
2. Control the temperature of the fluids inside the nozzle 
3. Print a wide range of collagen concentration from only the three 




If the bioprinting nozzle accomplished all of these goals, it would be the first 
3D bioprinter to use oligomeric type I collagen, and the first bioprinter to print a 
tissue construct with a heterogeneous ECM concentration from a single 
biomaterial. Not only would the system be able to print multiple concentrations of 
collagen, and therefore different fibril densities, but it would be able to print a 




CHAPTER 2. MATERIALS AND METHODS 
Design of the 3D Bioprinting Nozzle 
 
Figure 9. Complete system diagram. 
 
Design of the complete bioprinting nozzle, as shown in Figure 9, was broken into 
four steps:  
1. Chamber design, modeling, and fabrication 
2. Solution dispensing 




4. Evaluation and optimization of nozzle for printing self-assembling 
collagen 
 
Type I Oligomeric Collagen Preparation 
Type I oligomeric collagen was acid-solubilized from the dermis of market weight 
pigs and lyophilized for storage as described previously (Bailey 2011). According 
to ASTM International standard F3089-14, the oligomeric formulation was 
standardized on the basis of polymerization capacity and molecular composition 
(ASTM F3089-14 2014). Polymerization capacity is defined by the shear storage 
modulus G’, in Pa, as a function of oligomer concentration.  
 
Design, Computational Modeling, and Fabrication of Mixing Chamber 
Figure 10. CAD drawings of the designed mixing manifold from a top-down view, a); and 
from an orthogonal view. 
 
A mixing manifold was designed to achieve continuous mixing of three 
fundamental reagents, oligomer, diluent, and S.A.R, needed to produce self-
assembling collagen-fibril matrices over a broad range of microstructure-




included biocompatibility, chemical resistance, sterilizability, and adequate 
thermal conductivity to facilitate temperature control. 
The chamber was designed to include three channels (0.06” in diameter), 
with the two outer channels offset from the central channel by an angle of 30 
degrees. The diameter of the two outer channels narrowed to 0.03” as the two 
outer channels intersected the central channel (Figure 11). According to Gobby 
and co-workers, this angle of 30 degrees supports optimal mixing efficiency for 
passive, microfluidic T-mixers (Gobby 2001). Narrowing of the outer two 
channels was done to increase the velocity of the two outer streams of fluid 
(Diluent and S.A.R) at the point of combination with the oligomer. Decreasing the 
diameter of channels induces a venturi effect on the fluids, which was shown to 
further increase the mixing efficiency in angled T-mixers (Gobby 2001). Holes for 
three, 1/4-28 barbed fittings were added to the nozzle at the end of each channel 





Figure 11. Schematic of the nozzle with dimensions of mixing chamber and channels for 
reference. 
 
Immediately following the intersection of the three channels, a mixing 
chamber was added (0.093” in diameter) to ensure thorough mixture quality. To 
aid in this, a disposable static mixer was placed in the mixing chamber (Nordson 
EFD; East Providence, RI). Twisted channel mixing mechanisms induce complex 
fluid dynamics, and are commonly added in mixing applications to increase the 
mixing efficiency and mixture quality (Thakur 2003). For easy removal of the 
static mixer, the mixing chamber was not made to fully house the static mixer, as 






Figure 12. Protruding end of the static mixer before the needle has been screwed into 
place. 
 
The needle was used to house the protruding end of the static mixer, and 
to direct the flow of neutralized collagen onto the substrate. To minimize the 
surface tension between the deposited collagen and the needle, the end of the 
needle was machined into a cone. A small hole was machined into the cone-
shaped end (.0295” in diameter) to focus the deposition of collagen.  
 
Computational Modeling 
Computational modeling was performed to ascertain the value of narrowing the 
outer channels before they intersected at the inner channel. Two 2D models of 
the nozzle channels were constructed in a CAD program (Solidworks, Dassault 
Systems) and imported into COMSOL Multiphysics 5.2. One model did not have 
narrowed outer channels, and the other had channels narrowed to 0.03” in 




physics was selected, as initial calculations suggested the flow in the channels 
would not reach turbulent levels.  
 Reynolds number was calculated using the following formula for pipe flow: 




Where 𝑄 is equal to the flow rate, 𝐷 is equal to the diameter of the pipe 
(0.06” if not narrowed, and 0.03” if narrowed), 𝑣 is the kinematic viscosity, and 𝐴 
being equal to the pipe cross-sectional area. 
Flow rates at each inlet to the three inlet channels were estimated from 
the conversion of expected 3D flow rates to 2D flow rates, and the average fluid 
velocity was measured at the entrance to the mixing chamber. The average fluid 
velocity was calculated by averaging the fluid flow velocity vectors along a 
horizontal line extending from one side of the entrance to the mixing chamber to 
the other. This vector was then converted into a magnitude and compared across 
other fluid simulations. This was done for both narrowed and unchanged 
diameter models. The materials in the models were varied between using water 
as all three reagents, and having water as the reagents in the outer two 
channels, and a material simulating the viscosity of the oligomer in the central 
channel. Percent increase in fluid velocity was calculated by comparing the 
average fluid velocities of two simulations using the same fluid and inlet 
conditions, but different channel geometry.  
 
Nozzle Fabrication 
Fabrication of the main body of the nozzle was done by a separate company 
(Wirecut Industries, Indianapolis, IN). The needle was fabricated in-house. Both 




steel. This metal exhibits acceptable biocompatibility properties, is autoclaveable, 
and has excellent thermal conductivity.  
 
Solution Dispensing 
To control the concentration of printed collagen, the ratio of the flow rates of 
oligomer and diluent were varied. Varying the ratio of flow rates of these two 
reagents changed the final concentration of the neutralized collagen. Control of 
solution dispensing was performed by three lead-screw driven syringe pumps 
(New Era Syringe NE-500, Farmingdale, NY), independently controlled by a GUI 







Figure 13. Screenshot of the GUI developed in-house, to control the 3D bioprinting 
system. 
 
The GUI was developed in MATLAB (Mathworks, 2014), and the summarized 




1. The user specifies which reagent is loaded in each syringe pump 
2. The user selects what brand and size of syringe each reagent is in 
3. The user inputs the collagen concentration of the oligomer  
4. The user inputs the desired concentration of printed, neutralized 
collagen that is to be dispensed from the printer 
a. If the user requires a single concentration, input the same 
concentration for both the initial concentration and final 
concentration of printed collagen 
b. If the user requires a linear gradient of collagen 
concentration, input the desired initial concentration, and the 
final concentration of the printed collagen 
5. The user selects the total volume of collagen to be dispensed from 
the nozzle 
 
Evaluation and optimization of nozzle for printing self-assembling collagen 
3D bioprinting nozzle performance was validated in terms of: 
1. Separate reagent dispensed volume accuracy  
2. Simultaneous reagent dispensed volume accuracy  
3. Mixing quality 
4. Viscoelastic properties of self-assembled collagen 
5. Gradient formation 





Separate reagent dispensed volume accuracy 
Dispensed volume accuracy was measured using one syringe pump and 
dispensing either oligomer or water through the middle inlet channel or either of 
the side inlet channels, respectively. Water was used an analog for the diluent 
and the S.A.R, as their viscosities are similar.  
 
Water was placed into a 10cc syringe (BD Biosciences; San Jose, CA) 
and secured into the syringe pump. The outlet of the syringe was attached to a 
side inlet port of the bioprinting nozzle using flexible tubing. Three samples of 
water (n=3) were dispensed (50, 100, 500, and 1000 uL) at each flow rate (10, 50 
and 100 uL/sec) and weighed (Sartorius BP 210D; Goettingen, Germany). After 
completion, the 10cc syringe of water was replaced by a 20cc syringe of water, 
and the process was repeated. Once it had been repeated with the larger 
syringe, the entire experiment was conducted again with un-neutralized collagen 
attached to the middle inlet port of the nozzle.  
 
Simultaneous reagent dispensed volume accuracy 
Three different fluorescent dyes, Rhodamine 110 (Sigma, St. Louis, MO), 
Rhodamine 6G (Sigma), and Rhodamine B (Sigma) were added to the diluent 
(0.4 mg/ml), oligomer (0.4 mg/ml), and S.A.R (0.2 mg/ml), respectively. Hand-
mixed and printed reagents were all made to achieve final neutralized collagen 
samples made from the dyed reagents. These samples were made at 
concentrations of 1.34, 1.92, 2.36, 2.73 and 3.06 mg/mL. Fluorescence of the 
hand-mixed and printed samples was measured in a spectroflourometer at 
excitation/emission wavelengths of 496/520, 526/555, and 550/625 for 
rhodamine 100, 6G and B, respectively (Spectramax i3x, Molecular Devices, 





Dispensed volume accuracy of each reagent was measured by comparing 
the fluorescence values of printed and hand-mixed samples for corresponding 
collagen concentrations. 400 μL of each concentration was hand-mixed using the 
dyed reagents, and from that, three, 100 μL samples were plated into three wells 
of a 96 well plate (Costar; Sigma), (n=3). For printed samples, 150 μL of each 
concentration was printed from the nozzle, into a 1.5 mL Eppendorf tube.100 μL 
of that was plated into a well of a 96 well plate. This process was repeated three 
times (n=3). After three samples of each concentration had been plated, the plate 
was placed in an incubator, held at 37 °C and 5% CO2 for ten minutes to allow for 
complete polymerization of samples. This process was repeated three times 
(N=3). After the final incubation, the fluorescence of all samples was measured 
(Spectramax i3x; Molecular Devices, Sunnyvale, CA). Accuracy was determined 
using the formula: 
 





Where the accepted value corresponded to the value of the hand-mixed 
samples and the experimental value corresponded to the value of the printed 
sample for each reagent.  
Precision was calculated using the following equation: 
 





Where µ was the average fluorescent intensity for each reagent, and 𝑠𝑛 






Mixing quality is defined as the coefficient of variation (Statiflo 2016). As such, 






Where average was the mean of the nine fluorescent values of each 
reagent of both hand-mixed or printed samples, and similarly, the standard 
deviation of the nine fluorescent values.  
 
Viscoelastic properties of self-assembled collagen  
Batches of oligomeric collagen are subject to a quality control process, as 
defined by the ASTM standard guidance document (ASTM F3089–14 2014). In 
accordance with this document, quality control was done through rheometric 
testing of the polymerization capacity of the collagen. Three printed collagen 
samples were made at each of the aforementioned concentrations, and printed 
directly onto the rheometer base (AR2000; TA Instruments, Newcastle, DE), (n = 
3) at volumes of 950 µL. These samples were compared to the standard curve of 
the batch of collagen the reagents were taken from, and their storage moduli 
were compared to three hand-mixed samples as the gold standard with a 
standard t-test analysis of means; significance was determined with α<0.05. 
 
Gradient Formation 
A custom polymerization chamber was fabricated for the polymerization of 3 mLs 
of oligomeric collagen. The chamber was held under the nozzle and, as the 
nozzle dispensed 3 mL of collagen concentration starting at .5 mg/mL and ending 
at 4 mg/mL, was moved along its longer axis to facilitate gradient formation. 
Afterwards, the collagen was placed inside an incubator held at 37°C and 5% 
CO2 for 30 minutes, and the resulting structure was imaged using confocal 




microstructure to be visualized, to qualitatively compare the relative fibril density 
of different locations along the length of the structure.  
 
Cell Viability 
Cell viability was measured using 0.4% trypan blue cell viability assay (Strober 
2001). Neonatal human dermal fibroblasts (Lonza; Mapleton, IL) were cultured in 
Dulbecco’s modified Eagle’s Medium (DMEM; Sigma, St. Louis, MO) and 
supplemented with 10% fetal bovine serum (FBS, Sigma), 100U/ml penicillin 
(Gibco, Carlsbad, CA) and 100 μg/ml streptomycin (Gibco). Cells were 
maintained in a humidified environment of 5% CO2 at 37°C over a period of two 
weeks, and split at 90% confluence. Cells suspended in DMEM were placed in a 
3cc syringe at a concentration of 5x105 cells/mL, and loaded into a syringe pump. 
The syringe was attached to a side channel of the bioprinting nozzle via a flexible 
rubber tube, and 500 uL of media and cells were deposited in a 48 well plate at 
varying flow rates (1000, 100 and 10 uL/sec). 500 uL of fibroblasts in media was 
taken from the stock solution, without being printed, for the negative control. This 




All measurements are reported as mean ± standard deviation. Statistical 
analyses were performed with SAS v.  17 (SAS Institute, Cary, NC).  To 
determine differences among treatment groups, the general linear model 
procedure (GLM) was used to conduct unbalanced analysis of variance (ANOVA) 
and perform multiple comparisons of least squares means using the Tukey-
Kramer method. For simultaneous reagent dispensed volume accuracy analysis, 
a completely blocked three factor ANOVA was used to determine significant 
effects of syringe size, reagent viscosity, flow rate, total volume programmed to 





by the nozzle. Differences were considered significantly different with the critical 




CHAPTER 3. RESULTS AND DISCUSSION 
For the first step, it was necessary to quantitatively define mixing quality, as to 
have appropriate design criteria for the quality of the mixed reagents. Mixture 
quality was statistically defined as the mixture concentration’s coefficient of 
variation (Vanarase 2010, Günther 2006, Dreher 2009). This can be thought of 
as how evenly distributed the fluids are in the mixture. This is typically measured 
by sampling the concentration of a dilute solution in multiple places in the 
container it is stored in, and calculating the standard deviation between the 
measured concentration values. A typical objective for high mixing quality is 
between 0.01 and 0.05, which ensures complete homogeneity of the mixture 
(Statiflo 2016).  
 
Narrowing outer nozzle channels increased fluid velocity into the mixing 
chamber 
Reynolds number calculations returned a maximum value of 2.7 for the narrowed 
channel design and 2.3 for the unchanged channel design at the inlet to the 
mixing chamber, indicating that the fluid would not be in the turbulent range. This 
initial finding prompted the need for additional mixing strategies and confirmed 
the use of laminar flow for the channel flow simulations.  
Modeling nozzle channel geometry of both narrowed and unchanged 
channel diameters established that decreasing the outer channel diameter 
increased fluid velocity of fluid entering the mixing chamber. The effect of 
narrowing the channels can be seen visually in Figure 13, as the lighter color of 




velocity between the narrowed channel design and unchanged channel design is 
shown in Table 2.  
 
 
Figure 14. COMSOL models showing the effect of narrowing the outer channels on fluid 
velocity. Models were developed for A and B) Water flowing out of the nozzle at 10 μL/s, 
C and D) Water flowing at 100 μL/s, E and F) oligomer in the central channel with water 
in the outer channels at 10 μL/s, and G and H) oligomer in the central channel with water 
in the outer channels at 100 μL/s.   
 
Table 2. Average percent increase in fluid velocity in narrowed channel design 
compared to unchanged channel design. 
 Unchanged Channels Narrowed Channels Percent 
Increase    
(10 / 100) µL/s Expected 3D Flow Rate 
at Outlet (µL/s) 
10 100 10 100 
Water 0.004513 0.04510 0.00536 0.05438 18.8 / 20.6 
Oligomer 0.004453 0.04466 0.005342 0.05339 20.0 / 19.5 
 
 This data demonstrated the utility of decreasing the diameter of the outer 




chamber. Increased fluid velocity is beneficial in this instance, due to its positive 
correlation with mixing quality (Gobby 2001).  
 
Single reagent volume dispensing showed a significant flow rate and total 
volume interaction effect 
Statistical analysis of dispensed volume accuracy showed no significant effect of 
changing the syringe volume size, but significant effect of the interaction between 
flow rate and volume dispensed (α = 0.05), (Table 2). This significant interaction 
effect can be seen as a trend in the raw data of both water and oligomer for 
either syringe size (Figures 15a-15d). For the higher flow rates (500 and 1000 
uL/sec), the accuracy of the dispensed volume is positively correlated with the 







Figure 15. Single reagent dispensed volume accuracy for water (A and C), and 
Collagen (B and D) using 20cc (A and B) and 10cc (C and D) syringes. 
 
While the viscosity or size of reagent reservoirs does not affect the 
accuracy of the dispensed reagent volume, the accuracy does decrease as the 
flow rate increases for the smaller volumes dispensed (50 and 100 uL). The 
insignificance of fluid viscosity was most likely due to the choice of syringe 
pumps. Lead-screw driven pumps were chosen for this initial design iteration 
because they are able to maintain a constant flow rate over a much larger range 
of viscosities than pneumatically-driven syringe pumps. Pneumatic pumps 
require higher applied pressures to move higher-viscosity materials, as this 
requires more force. Lead-screw driven pumps are able to maintain a very high 
constant force, which facilitates more accurate fluid displacement over a broader 




sizes, this indicates that this system could benefit from larger reagent reservoirs; 
as this would lead to replacing empty syringe reservoirs less frequently.  
The significant difference in the interaction effect points to an inherent 
limitation of the pumping system. Lead-screw driven syringe pumps are not 
designed for the precise dispensing of small volumes of fluids. These pumps are 
designed to maintain a constant flow rate, usually on the order of uL/min, for 
hours at a time. This was made apparent by the pumps range of programmable 
dispensing time, from hours to tenths of seconds. Operating at the very lowest of 
the range of dispensing times most likely lead to this dispensing volume 
inaccuracy. 
 
Table 3. Significance of each variable for both water and oligomer dispensed volume 
accuracy experiments and the statistical difference between the fluids themselves. (p < 
0.05 denotes statistical significance) 
Fluid Water Oligomer   
Variable Syringe Volume Flow Vol* 
Flow 
Syringe Volume Flow Vol* 
Flow 
Fluid 
p-value 0.33 < 0.05 < 0.05 < 0.05 0.21 < 0.05 < 0.05 < 0.05 0.86 
 
 
Dispensed volume accuracy revealed inaccurate S.A.R delivery during 






Figure 16. Fluorescent values for each reagent in hand-mixed and printed 
samples.     Denotes significance (p < 0.05). 
 
Table 4. p-values comparing fluorescent intensity of printed samples to hand-mixed 
samples, for each reagent, and target stiffness. (p < 0.05 denotes statistical significance) 
 200 400 600 800 1000 
Diluent 0.217 0.37 0.671 0.317 0.819 
Oligomer 0.814 0.487 0.236 0.145 0.198 
S.A.R 0.064 0.043* 0.006* 0.027* 0.02* 
 
Both diluent and oligomer were able to be dispensed accurately (>90%); 




samples (Figure 16, Table 3). This could be explained by a limitation in the 
pumping system. The total volume of S.A.R dispensed was much lower than that 
of diluent or oligomer, and the pumping system was not designed to accurately 
pump small volumes of fluid at high pressures for short durations (as seen in the 
single regent volume accuracy data), and into other streams of pressurized fluid. 
This could have resulted in the significant decrease in S.A.R delivery into the 
final samples.  
 
Table 5. Dispensed volume accuracy, precision and mixing quality for printed samples. 
  Diluent Oligomer  S.A.R 
Accuracy 94.50% 94.10% 53.20% 
Precision ± 7.6% ± 5.1% ± 12.3% 
Mixing Quality 0.1 0.07 0.17 
 
 The mixing quality and precision of printed samples were both lower than 
that of hand-mixed samples (Table 5).  Mixing quality of hand-mixed samples 
were less than 5%, indicating a well-mixed fluid. This result partially validated the 
experimental method, and was used as the gold standard. Mixing quality of the 
printed samples was lower than that of hand-mixed samples. Furthermore, the 
measured decrease in precision seen in printed samples indicated a need for a 
more precise, reliable pumping system.  
 
Table 6. Mixing Quality and Precision of printed samples compared to hand-mixed 
samples. 
    Diluent Oligomer  S.A.R 
Hand-Mixed 
Mixing Quality 0.033 0.046 0.043 






Table 6 Continued.  
Printed 
Mixing Quality 0.1 0.07 0.17 
Precision ± 7.60% ± 5.10% ± 12.30% 
 
Shear storage modulus of printed samples are similar to hand-mixed 
samples 
 
Table 7. Shear storage modulus (G’) of hand-mixed and printed samples. * Indicates 
significance (α < 0.05). 
Target Stiffness 
(Pa) 
1000  800  600  400  200  
Hand-Mixed 1109 ± 59* 861 ± 24 620 ± 29* 375 ± 49 199 ± 8.7* 
Printed 703 ± 86* 698 ± 67 480 ± 44* 344 ± 48 171 ± 3.5* 
 
 
Table 8. Statistical analysis of the difference between shear storage modulus of hand-
mixed and printed samples. 
Target Stiffness 1000 800 600 400 200 
p-value < 0.05 0.058 < 0.05 0.475 < 0.05 
 
For all concentrations tested, the shear storage modulus of printed samples was 
lower than that of hand-mixed samples (Table 6). The most likely cause for this 
decrease in mechanical stiffness is the decrease in S.A.R dispensed in the 
printed samples (Table 5). The S.A.R is responsible for the neutralization of the 
final collagen sample. If the final pH of the collagen sample did not reach neutral 




incomplete polymerization of samples; thus, resulting in lower stiffness values. G’ 
of printed samples does approach hand-mixed and target values in the lower 
stiffness range (200 – 400 Pa). This could be a result of interaction effects 
between S.A.R and the flow of oligomer, which increases as the target stiffness 
increases, possibly making it more difficult for the relatively small amount of 
S.A.R to be dispensed properly.  
 
The bioprinting nozzle is able to dispense a gradient of collagen 
concentration within the same tissue construct 
The microstructure of the 3 mL gradient tissue construct was analyzed using 
reflectance imaging. The resulting fibril structures indicate that one end of the 
tissue construct had a lower fibril density than the opposing side, and in between 
the two extremes, a fibril density that is an average of the two, as shown in 
Figure 17.  
 
 
Figure 17. Tissue construct in fabricated well, with confocal reflectance images of the 
collagen microstructure taken at three locations along the length.  
 




Cell viability of printed cells in media was not significantly different than the 
negative control (Figure 10). This indicates that the narrowing of the side 
channel, mixing of the fluid in the mixing chamber, and final extrusion through the 
needle, did not cause enough shear force to significantly affect the cell viability of 
fibroblasts. Furthermore, there was no significant difference in cell viability 
between cells dispensed at any of the tested flow rates, suggesting that flow rate 
could be increased without having a deleterious effect on cell health. Increasing 




Figure 18. Viability of cells printed at 10, 100, and 1000 μL/s compared to the positive 





For this experiment, a 3cc syringe was used after the previous attempts of 
using a 10cc syringe were done for 10 and 100 uL/sec resulted in low cell density 
measured, as shown in table 9. After changing to the 3cc syringe, cell densities 
improved.  
 
Table 9. Average cell viabilities for each flow condition, the standard deviation, and the 
statistical significance of the average cell viability of each flow condition compared to the 
cells not dispensed through the mixer. (p < 0.05 denotes statistical significance) 
 Flow Condition 
10 μL/s 100 μL/s 1000 μL/s Starting Cell 
Suspension 
Cell Viability 80% 86% 75% 85% 
Stdev. 4.2 3.5 5.1 4.3 
p-value 0.373 0.78 0.224 - 
 
Table 10. Cell density results for 10cc syringe and 3cc syringe sizes. 
 
 The hypothesized reason for these low cell densities was cell settling in 
the media. The syringe with cells in media was placed horizontally on the syringe 
pump, and it was thought that after the time taken to calculate the cell viability of 
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the bottom edge of the syringe. When the next samples were dispensed from the 
collagen, the majority of cells had settled to the bottom of the syringe, resulting in 
decreased cell densities.  
 To overcome problems with cell settling, a 3cc syringe was used so that 
after three samples had been printed and measured for cell viability, the stock 
solution was mixed, and 2 mL was taken into the syringe and immediately 
printed. This approach reduced the time that cells were in the reservoirs, and 




CHAPTER 4. CONCLUSIONS AND FUTURE WORK 
Implications for fluidic mixing 3D bioprinters 
The experiments presented in this study have proven the potential for a fluidic 
mixing nozzle that can dispense a broad range of ECM concentrations in a single 
tissue construct. The mixing nozzle prototype was able to dispense accurate 
volumes of two of the three reagents needed for oligomeric type I collagen during 
simultaneous pumping, but dispensed significantly less S.A.R than was required. 
The nozzle was found to create collagen samples that were similar to the 
stiffness of hand-mixed samples, was able to print a gradient of collagen 
concentrations in the same tissue construct, and was found to not significantly 
decrease cell viability of printed fibroblasts.  
 
Limitations needed to be addressed for the next prototype iteration 
Limitations of the pumping system contributed to inaccurate volumes of 
dispensed reagents, as seen directly from the dispensed volume accuracy data. 
This effect was negated as much as possible by choosing a flow rate that had 
been measured to be the most accurate during single reagent dispensing, but a 
new pumping system that is designed for small volume fluid dispensing will need 
to be procured for the next iteration of the mixing nozzle prototype. 
Fluorescence data measured that the mixing quality of printed volume 
fraction samples was less than those of hand-mixed samples, as well as 
precision of reagent volume dispensed. This again raises the need for a pumping 
system designed for this specific application. Mixing quality and precision should 




reagents during simultaneous dispensing. Increasing the flow rate of the 
reagents would also improve mixing quality, but would need to be balanced by 
the effect it would have on cell viability.  
Final stiffness values of samples printed were lower than those of hand-
mixed samples, and in conjunction with the reagent volume data, was explained 
by the lack of S.A.R in printed samples. A more accurate pumping system and 
would account for the differences seen between printed and hand-mixed volume 
fraction samples for the rheometric experiment. Accurate pumping will ensure 
that the correct amount of reagents are being dispensed, leading to the complete 
neutralization.  
The cell viability results suggested that this method of mixing and 
combining fluids does not decrease cell viability significantly from cells not 
extruded through the nozzle. Further experiments using cells encapsulated in 
oligomeric collagen may provide a more relevant result regarding the cell viability 
of cells printed in collagen, as this is the environment the cells would be 
encapsulated in the mixing chamber and being extruded through the nozzle.  
 
Future Work 
The results presented in this thesis identify future design improvements and 
experiment design that need to be completed to further the next prototype 
design. Specific areas of investigation include 1) Improving the reagent pumping 
system, 2) Reliable temperature control, 3) Direct quantification of fluidic mixing 
quality and efficiency, and 4) More relevant cell viability studies. By addressing 
these questions with specifically designed experiments, we can provide thorough 
validation results for the next bioprinting nozzle, and build off of the key findings 
from this research.  
Firstly, a new pumping system should replace the current setup, as the 




to be a final solution. The new pumping system should be designed to deliver 
very small volumes of reagents against a high-pressure. Metering pumps or 
similar systems might prove to be the best option for the next design of nozzle. 
This will allow for the correct volumes of each reagent to be dispensed, 
regardless of viscosity or flow rate of the other reagents being pumped into the 
nozzle simultaneously, which is essential for this project. 
Next, full control over the reagent temperatures is needed to ensure that 
polymerization of the collagen does not occur in the nozzle. For this proof-of-
concept design, temperature control was accomplished with direct contact with 
packs of ice, but this technique was difficult to manage, and constantly needed 
maintenance. Full temperature control could be done by machining channels into 
the nozzle that are pumped with chilled water- cooling the nozzle. Cooling of the 
syringe reservoirs should also help ameliorate any foreseeable issue.  
The direct quantification of fluidic mixing quality and efficiency is 
paramount in the next version of the bioprinting nozzle. To do this, a new testing 
method must be developed to directly, and more accurately, measure the mixing 
quality and efficiency of each reagent. Using this test, optimization of flow rates 
and mixing strategies could be undergone to achieve a desired mixing quality, 
and improve mixing efficiency. 
More relevant cell studies are needed to accurately predict the cell viability 
of printed cells in oligomeric collagen. The current cell viability studies were done 
with cell media, which has a much lower viscosity than the oligomeric collagen. 
This difference in viscosity may result in differences in cell viability. Different cell 
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